Description
A bioactive sphingolipid; agonist of S1P1, S1P2, and S1P3 (EC50s = 167.7, 368.1, and 482.6 nM, respectively, for the human receptors); agonist of ORG1 that induces calcium accumulation in cells overexpressing OGR1 (EC50 = ~35 nM); levels are increased in skin isolated from patients with atopic dermatitis, as well as postmortem brain from patients with Niemann-Pick disease type A
Formal name: 2-[[[[2S-amino-3R-hydroxy-4E-octadecenyl]oxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-ethanaminium
Synonyms: D-erythro Lyso SM(18:1)|D-erythro Sphingosine-1-Phosphocholine (d18:1)|D-erythro-Sphingophosphorylcholine|Lyso-SM(d18:1)|Lysosphingomyelin (d18:1)
Molecular weight: 464.6
CAS: 1670-26-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sphingolipids||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience